Clinical Trial Update: SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

View source ↗

Summary

The SEP-SEQ trial completed evaluating a sequencing-based diagnostic assay for determining the microbial etiology of sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Karius, Inc. | Conditions: Sepsis | Status: COMPLETED